Monoclonal antibody (mAb) therapy involves making large amounts of antibodies that recognize antigens that are usually found on the surface of cancer cells. They are then injected into the body ...

Country Bowls club teamed up with the Golfers from La Torre Golf Society to have a Bowls Pro-Am event in aid of our nominated ...

AbbVie is looking at combining lemzoparlimab with its blood cancer therapy Venclexta (venetoclax) in clinical trials. According to I-Mab, its antibody has a lower tendency than other anti-CD47 ...

Feb. 7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

CARTAGENA has officially revived a military tradition with the return of the cañonazo (cannon salute) at the Arsenal Militar, ...

Y-mAbs Therapeutics, Inc. (YMAB) stock has reached a 52-week low, trading at $5.69, as the company faces a challenging market environment. According to InvestingPro data, this represents a dramatic 73 ...

Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, ...

Jan. 15, 2025 — In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive ...

At closing of the transaction, JASMIN shall acquire Pierre Fabre's R&D Centre (including R&D Site and R&D activities) at Saint-Julien-en-Genevois, France, and JBIRSPL would also execute a Shareholders ...